{"nct_id":"NCT01888471","title":"Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2013-12-11","start_date_type":"ACTUAL","primary_completion_date":"2014-07-14","primary_completion_date_type":"ACTUAL","completion_date":"2014-07-14","completion_date_type":"ACTUAL","phases":["NA"],"tickers":["GSK"]}